Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

Autor: Perez Elias, MJ, Alejos, B, Vivancos, MJ, Ribera, E, Galindo, MJ, Vilanova-Trillo, L, Fraile, LJGF, Moral, SDL, De Lomas, JG, Lozano, F, Garcia, MGM, Pitarch, MT, Martinez, MD, Rojas, J, Raya-Cruz, M, Sepulveda, MA, Troya, J, Del Campo, S, Martinez, E, Callau, P, Moreno, A, Casado, JL, Sanchez, JM, Ayerbe, CG, Negredo, E, Campos, I, Puig, J, Torrella, A, Planas, B, Knobel, H, Ferrando, R, Crespo, M, Ocampo, A, Sanz, J, de Los Santos, I, Diaz, A, Carbonero, LM, de la Torre, J, Reina, MR, Santos, J, Maria, C, Domenech, G, Gutierrez, MM, Montero, M, Cuellar, S, Boix, V, Payeras, A, Ryan, P, Torralba, M, Cuadra, F, Aznar, E, Esteban, H, de Miguel, M, Gonzalez, P, Yllescas, M

Publikováno v: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background Few women have been included in darunavir/cobicistat clinical development studies, and hardly any of them were antiretroviral experienced or treated with anything other than triple-based therapies. Objectives Our aim was to increase our kn

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::6906439be0e154ba4ffa352f2292be69
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2404

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)

Autor: Perez Elias, MJ, Alejos, B, Vivancos, MJ, Ribera, E, Galindo, MJ, Vilanova-Trillo, L, Fraile, LJGF, Moral, SDL, De Lomas, JG, Lozano, F, Garcia, MGM, Pitarch, MT, Martinez, MD, Rojas, J, Raya-Cruz, M, Sepulveda, MA, Troya, J, Del Campo, S, Martinez, E, Callau, P, Moreno, A, Casado, JL, Sanchez, JM, Ayerbe, CG, Negredo, E, Campos, I, Puig, J, Torrella, A, Planas, B, Knobel, H, Ferrando, R, Crespo, M, Ocampo, A, Sanz, J, de Los Santos, I, Diaz, A, Carbonero, LM, de la Torre, J, Reina, MR, Santos, J, Maria, C, Domenech, G, Gutierrez, MM, Montero, M, Cuellar, S, Boix, V, Payeras, A, Ryan, P, Torralba, M, Cuadra, F, Aznar, E, Esteban, H, de Miguel, M, Gonzalez, P, Yllescas, M, CODAR Study Grp

Publikováno v: The Journal of antimicrobial chemotherapy
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

Background Few women have been included in darunavir/cobicistat clinical development studies, and hardly any of them were antiretroviral experienced or treated with anything other than triple-based therapies. Objectives Our aim was to increase our kn

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9150487724f34cbeca87fff53159f762
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3932